McKesson Co. (NYSE:MCK) CEO Brian S. Tyler Sells 8,678 Shares of Stock

McKesson Co. (NYSE:MCKGet Rating) CEO Brian S. Tyler sold 8,678 shares of McKesson stock in a transaction that occurred on Wednesday, May 11th. The shares were sold at an average price of $331.45, for a total transaction of $2,876,323.10. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Brian S. Tyler also recently made the following trade(s):

  • On Monday, May 9th, Brian S. Tyler sold 5,438 shares of McKesson stock. The shares were sold at an average price of $330.93, for a total transaction of $1,799,597.34.
  • On Friday, April 29th, Brian S. Tyler sold 5,438 shares of McKesson stock. The shares were sold at an average price of $319.36, for a total transaction of $1,736,679.68.
  • On Monday, April 18th, Brian S. Tyler sold 5,438 shares of McKesson stock. The shares were sold at an average price of $323.25, for a total transaction of $1,757,833.50.

NYSE:MCK opened at $322.01 on Friday. McKesson Co. has a 12 month low of $184.43 and a 12 month high of $339.94. The company has a 50 day simple moving average of $309.85 and a two-hundred day simple moving average of $266.44. The company has a market cap of $46.81 billion, a PE ratio of 44.66, a price-to-earnings-growth ratio of 1.51 and a beta of 0.67.

McKesson (NYSE:MCKGet Rating) last issued its quarterly earnings data on Thursday, May 5th. The company reported $5.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.06 by ($0.23). McKesson had a net margin of 0.42% and a negative return on equity of 538.84%. The business had revenue of $66.10 billion for the quarter, compared to the consensus estimate of $63.82 billion. During the same period in the previous year, the firm earned $5.05 EPS. The company’s revenue was up 11.8% on a year-over-year basis. As a group, equities analysts predict that McKesson Co. will post 23.2 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 1st. Stockholders of record on Wednesday, June 1st will be given a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date of this dividend is Tuesday, May 31st. McKesson’s payout ratio is 26.07%.

Several hedge funds have recently modified their holdings of MCK. Center for Financial Planning Inc. grew its position in shares of McKesson by 4.9% during the 3rd quarter. Center for Financial Planning Inc. now owns 4,777 shares of the company’s stock valued at $952,000 after acquiring an additional 222 shares during the period. JustInvest LLC lifted its stake in shares of McKesson by 28.8% during the 3rd quarter. JustInvest LLC now owns 2,833 shares of the company’s stock valued at $565,000 after buying an additional 634 shares in the last quarter. Boston Private Wealth LLC lifted its stake in shares of McKesson by 17.4% during the 3rd quarter. Boston Private Wealth LLC now owns 3,584 shares of the company’s stock valued at $715,000 after buying an additional 532 shares in the last quarter. Barclays PLC lifted its stake in shares of McKesson by 6.7% during the 3rd quarter. Barclays PLC now owns 558,363 shares of the company’s stock valued at $111,323,000 after buying an additional 34,957 shares in the last quarter. Finally, Sawtooth Solutions LLC purchased a new position in shares of McKesson during the 3rd quarter valued at $223,000. 85.45% of the stock is owned by hedge funds and other institutional investors.

Several equities analysts have recently issued reports on the stock. Morgan Stanley lifted their target price on shares of McKesson from $292.00 to $370.00 and gave the company an “overweight” rating in a report on Tuesday, April 12th. UBS Group raised their price target on shares of McKesson from $245.00 to $303.00 and gave the company a “buy” rating in a research report on Tuesday, February 8th. Credit Suisse Group raised their price target on shares of McKesson from $333.00 to $377.00 in a research report on Wednesday. StockNews.com assumed coverage on shares of McKesson in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, Cowen raised their price target on shares of McKesson from $325.00 to $361.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $320.08.

About McKesson (Get Rating)

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).

Recommended Stories

Insider Buying and Selling by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.